Startup Now: What Would Your Startup Do With $250,000 in 2009?
Event Details
Time: April 7, 2009 from 5pm to 7pm
Location: RCC/SOU Higher Education Center
Street: 101 8th Street
City/Town: Medford, Oregon
Website or Map: http://younoodle.com/groups/s…
Event Type: business, capital, jobs
Organized By: Startup Now Oregon
Latest Activity: Apr 6, 2009
Event Description
Join Oregon's entrepreneurs Tuesday evening April 7th, at 5:00 PM at HEC to explore and answer the question "What Would Your Startup Do With $250,000 in 2009?"
In the last 6 months the economy, access to capital, the cost of talent and the opportunities for innovation have all changed. We think it’s time for the relationship between entrepreneurs and the State of Oregon to change, too (the state needs jobs & entrepreneurs need capital!).
Hear stories of successful, local homegrown companies that have either bootstrapped or raised funds and then grown themselves to success.
Most importantly, though, the goal of this event is to prove to the State of Oregon that there are enough jobs, compelling ideas and entrepreneurs to warrant an immediate investment of $100,000,000 for startups that want to hire local talent.
We are working to raise a $100M fund that makes small investments in Oregon-based companies who hire Oregon-based employees. Now, in 2009. Not next year or some point in the future. In growing these new startups, we are investing in innovation, creating jobs and building Oregon’s brand with innovators and entrepreneurs.
Please be prepared to answer the following questions:
- Could your company hire $250,000 worth of Oregon-based talent in 2009 to get it to the next level?
- What could your company achieve during 2009 with a $250,000 investment?
- How many new jobs could we create if 400 new Oregon startups were funded?
- How would you like to see $100,000,000 invested in Oregon startups?
Brought to you in part by SOREDI, Jefferson Grapevine, Capybara Ventures, NW Technology Ventures, NedSpace, Oregon Angel Fund, Oregon Entrepreneurs Network, Starve Ups Reference Capital and the Software Association of Oregon.
HEC is proud to host an Oregon entrepreneurial startup event during this unparalleled time of economic disruption. Be a part of this unparalleled movement!
Paul Mace - [email protected] (541) 840-2994
Wayne Embree - [email protected] (503) 619.4310
Josh Friedman - [email protected] (503) 705.7975
Mark Grimes - [email protected] (503) 502.0185
Harvey Mathews - [email protected] (503) 999-5849
Marybeth Buonassissi, Office Manager
~ Southern Oregon Regional Economic Development, Inc. (SOREDI)
673 Market Street, Medford, OR 97504
(541) 773-8946
Comment Wall
Coronavirus News
Explosive If True: “I’m a Clinical Lab Scientist, C19 Is Fake, Wake up America” | The True Defender !
What we found was that all of the 1500 samples were mostly Influenza A and some were influenza B, but not a single case of Covid, and we did not use the B.S. PCR test. We then sent the remainder of the samples to Stanford, Cornell, and a few of the University of California labs and they found the same results as we did, NO COVID. They found influenza A and B. All of us then spoke to the CDC and asked for viable samples of COVID, which CDC said they could not provide as they did not have any samples. We have now come to the firm conclusion through all our research and lab work, that the COVID 19 was imaginary and fictitious. The flu was called Covid and most of the 225,000 dead were dead through co-morbidities such as heart disease, cancer, diabetes, emphysema etc. and they then got the flu which further weakened their immune system and they died. I have yet to find a single viable sample of Covid 19 to work with. We at the 7 universities that did the lab tests on these 1500 samples are now suing the CDC for Covid 19 fraud. the CDC has yet to send us a single viable, isolated and purifed sample of Covid 19. If they can’t or won’t send us a viable sample, I say there is no Covid 19, it is fictitious. The four research papers that do describe the genomic extracts of the Covid 19 virus never were successful in isolating and purifying the samples. All the four papers written on Covid 19 only describe small bits of RNA which were only 37 to 40 base pairs long which is NOT A VIRUS. A viral genome is typically 30,000 to 40,000 base pairs.COVID-19 Nasal Swab Test Led To Cerebrospinal Fluid Leak | Forbes
Many who’ve had a nasal Covid-19 test performed on themselves have described it as feeling like that swab got as far back as their brains. If done correctly, the swab is angled parallel to the floor, all the way to the back of the nose, and the swab is rubbed on an area called the nasopharynx. The actual term is a nasopharyngeal swab, not nasal swab, because it’s the nasopharynx that contains the highest possible viral load to best determine an active Covid-19 infection. The distance from the average nasal tip to the nasopharynx is close to 6 inches. So if it feels like there’s a half a foot being stuck up your nose, well, you’re not so far off.US to Require Quarantine for All International Air Travelers | The Epoch Times
President Joe Biden on Jan. 21 issued an executive order that would require international air travelers to quarantine upon arrival to the United States.CDC says asymptomatic people don't need testing, draws criticism from experts | TheHill
The Centers for Disease Control and Prevention (CDC) quietly changed its guidance on Monday to now say that asymptomatic people do not need to be tested for coronavirus, even if they have been in close contact with an infected person. The agency made the move by updating its website but did not make any public announcement or explain the reasoning behind the major revision. The guidance now states: “If you have been in close contact (within 6 feet) of a person with a COVID-19 infection for at least 15 minutes but do not have symptoms: You do not necessarily need a test unless you are a vulnerable individual or your health care provider or State or local public health officials recommend you take one.”What Kind of Covid Test Should I Get? Answers on Cost, Accuracy and More | WSJ
There are two generally available types of Covid-19 tests. The first, and most commonly used so far, is a PCR test, which is short for polymerase chain reaction. It’s a molecular test, meaning it searches for the virus’s genetic material in a nasal swab or saliva sample, and it is often processed in a highly complex laboratory. There are two ways to collect a nasal sample: from the inside of a nostril, or from the back of the nose and throat. The second way, called a nasopharyngeal swab, requires a professional to probe more deeply into the nasal cavity to get the sample. Some testing sites may ask you to swab your nose or cheek yourself, or spit into a tube. Each of these collection methods creates a sample that can be analyzed with a PCR test. Antigen tests, which search the sample for viral proteins instead of the virus’s genetic code, are becoming more widespread in the U.S. Right now, antigen tests are typically offered at doctor’s offices, nursing homes, schools and other congregate settings where groups of people need testing fast.
© 2021 Created by Ashland Source Center.
Powered by
